Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 25 (2), 205-223
- https://doi.org/10.1016/0090-6980(83)90105-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cardiovascular effects of prostaglandin D3 and D2 in anesthetized dogsProstaglandins, 1981
- Heterocyclic prostaglandin analogues. Part 2. Hydantoins and other imidazole analoguesJournal of the Chemical Society, Perkin Transactions 1, 1980
- Desensitization of prostaglandin-activated platelet adenylate cyclaseProstaglandins, 1979
- Selective Binding Site for [3H]Prostacyclin on PlateletsJCI Insight, 1979
- Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 06-keto-PGF1α in the pulmonary circulationProstaglandins, 1978
- Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different speciesProstaglandins, 1978
- Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1α on the rat gastric mucosa in vivo and in vitroProstaglandins, 1978
- A comparison of the vasodepressor effects of the cyclic endoperoxides PGG2 and PGH2 with those of PGD2 and PGE2 in hypertensive and normotensive ratsEuropean Journal of Pharmacology, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Prostaglandin D2 inhibits the aggregation of human plateletsThrombosis Research, 1974